{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:29:24Z","timestamp":1779377364790,"version":"3.53.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jocn.2021.10.041","type":"journal-article","created":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T05:35:27Z","timestamp":1646976927000},"page":"164-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Changes of FSTL1 and MMP-9 levels in patients with acute cerebral infarction and its relationship with hemorrhagic transformation"],"prefix":"10.1016","volume":"99","author":[{"given":"Chenhan","family":"Ling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjie","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jocn.2021.10.041_b0005","first-page":"9855","article-title":"Comparative study on short-term and long-term prognostic determinants in patients with acute cerebral infarction","volume":"8","author":"Wang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.jocn.2021.10.041_b0010","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.clineuro.2019.04.018","article-title":"Influencing factors of hemorrhagic transformation in non-thrombolysis patients with cerebral infarction","volume":"181","author":"Jiao","year":"2019","journal-title":"Clin Neurol Neurosurg"},{"issue":"3-4","key":"10.1016\/j.jocn.2021.10.041_b0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000439548","article-title":"Hemorrhagic Transformation in Patients with Cerebral Infarction Referred to a Rehabilitation Hospital","volume":"4","author":"Maeshima","year":"2016","journal-title":"Interv Neurol"},{"issue":"1","key":"10.1016\/j.jocn.2021.10.041_b0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1432-1033.1993.tb18212.x","article-title":"Cloning from a mouse osteoblastic cell line of a set of transforming-growth-factor-beta 1-regulated genes, one of which seems to encode a follistatin-related polypeptide","volume":"217","author":"SHIBANUMA","year":"1993","journal-title":"Eur J Biochem"},{"issue":"24","key":"10.1016\/j.jocn.2021.10.041_b0025","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1161\/CIRCULATIONAHA.108.767673","article-title":"Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart","volume":"117","author":"Oshima","year":"2008","journal-title":"Circulation"},{"issue":"47","key":"10.1016\/j.jocn.2021.10.041_b0030","doi-asserted-by":"crossref","first-page":"32802","DOI":"10.1074\/jbc.M803440200","article-title":"Follistatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric-oxide synthase-dependent mechanism","volume":"283","author":"Ouchi","year":"2008","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.jocn.2021.10.041_b0035","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1002\/art.27485","article-title":"Follistatin-like protein 1 is a mesenchyme-derived inflammatory protein and may represent a biomarker for systemic-onset juvenile rheumatoid arthritis","volume":"62","author":"Wilson","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"1-3","key":"10.1016\/j.jocn.2021.10.041_b0040","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12026-014-8526-z","article-title":"Follistatin-like protein 1 and its role in inflammation and inflammatory diseases","volume":"59","author":"Chaly","year":"2014","journal-title":"Immunol Res"},{"key":"10.1016\/j.jocn.2021.10.041_b0045","doi-asserted-by":"crossref","unstructured":"Mattiotti, A., et al., Follistatin-like 1 in development and human diseases. 2018. 75(13): p. 2339-2354.","DOI":"10.1007\/s00018-018-2805-0"},{"issue":"16","key":"10.1016\/j.jocn.2021.10.041_b0050","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.2174\/1389557519666190312161551","article-title":"Follistatin-like 1 in Cardiovascular Disease and Inflammation","volume":"19","author":"Peters","year":"2019","journal-title":"Mini Rev Med Chem"},{"issue":"10","key":"10.1016\/j.jocn.2021.10.041_b0055","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1161\/STROKEAHA.114.006092","article-title":"Follistatin-like 1 attenuates apoptosis via disco-interacting protein 2 homolog A\/Akt pathway after middle cerebral artery occlusion in rats","volume":"45","author":"Liang","year":"2014","journal-title":"Stroke"},{"issue":"43","key":"10.1016\/j.jocn.2021.10.041_b0060","doi-asserted-by":"crossref","first-page":"E899","DOI":"10.1073\/pnas.1108559108","article-title":"Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload","volume":"108","author":"Shimano","year":"2011","journal-title":"PNAS"},{"issue":"14","key":"10.1016\/j.jocn.2021.10.041_b0065","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1161\/CIRCULATIONAHA.112.115089","article-title":"Therapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical models","volume":"126","author":"Ogura","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jocn.2021.10.041_b0070","doi-asserted-by":"crossref","unstructured":"Sundaram, G., et al., EGF hijacks miR-198\/FSTL1 wound-healing switch and steers a two-pronged pathway toward metastasis. J Exp Med, 2017. 214(10): p. 2889-2900.","DOI":"10.1084\/jem.20170354"},{"issue":"1","key":"10.1016\/j.jocn.2021.10.041_b0075","first-page":"13","article-title":"FSTL1 suppresses tumor cell proliferation, invasion and survival in non-small cell lung cancer","volume":"39","author":"Ni","year":"2018","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jocn.2021.10.041_b0080","doi-asserted-by":"crossref","unstructured":"Shi, D., et al., MicroRNA-27a Inhibits Cell Migration and Invasion of Fibroblast-Like Synoviocytes by Targeting Follistatin-Like Protein 1 in Rheumatoid Arthritis. Mol Cells; 2016. 39(8): p. 611-8.","DOI":"10.14348\/molcells.2016.0103"},{"issue":"12","key":"10.1016\/j.jocn.2021.10.041_b0085","doi-asserted-by":"crossref","DOI":"10.2174\/1389450118666170427151657","article-title":"A Therapeutic Target of Cerebral Hemorrhagic Stroke: Matrix Metalloproteinase- 9","volume":"18","author":"Dang","year":"2017","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.jocn.2021.10.041_b0090","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3389\/fphar.2020.00822","article-title":"Efficacy and Safety of Xueshuantong Injection on Acute Cerebral Infarction: Clinical Evidence and GRADE Assessment","volume":"11","author":"Lyu","year":"2020","journal-title":"Front Pharmacol"},{"issue":"11","key":"10.1016\/j.jocn.2021.10.041_b0095","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1161\/01.STR.30.11.2280","article-title":"Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort","volume":"30","author":"Fiorelli","year":"1999","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.jocn.2021.10.041_b0100","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1177\/1403494818773534","article-title":"Distribution of risk factors for cardiovascular disease and the estimated 10-year risk of acute myocardial infarction or cerebral stroke in Sami and non-Sami populations: The SAMINOR 2 Clinical Survey","volume":"46","author":"Siri","year":"2018","journal-title":"Scandin J Public Health"},{"key":"10.1016\/j.jocn.2021.10.041_b0105","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000487514","article-title":"Cerebral Haemodynamics following Acute Ischaemic Stroke: Effects of Stroke Severity and Stroke Subtype","volume":"8","author":"Osian","year":"2018","journal-title":"Cerebrovasc Dis Extra"},{"issue":"16","key":"10.1016\/j.jocn.2021.10.041_b0110","first-page":"8447","article-title":"Clinical significance of FSTL 1, Bax, Bcl-2 in acute cerebral infarction and its relationship with hemorrhagic transformation","volume":"24","author":"Liu","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.jocn.2021.10.041_b0115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10456-015-9464-7","article-title":"Matrix metalloproteinase-9 mediates post-hypoxic vascular pruning of cerebral blood vessels by degrading laminin and claudin-5","volume":"18","author":"Boroujerdi","year":"2015","journal-title":"Angiogenesis"},{"issue":"5","key":"10.1016\/j.jocn.2021.10.041_b0120","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s12975-017-0598-3","article-title":"Baicalin Attenuates Blood-Brain Barrier Disruption and Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke Rats with Delayed t-PA Treatment: Involvement of ONOO-MMP-9 Pathway","volume":"9","author":"Chen","year":"2018","journal-title":"Transl Stroke Res"},{"issue":"1","key":"10.1016\/j.jocn.2021.10.041_b0125","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1212\/WNL.0000000000009179","article-title":"Analysis of the association of MPO and MMP-9 with stroke severity and outcome: Cohort study","volume":"95","author":"Maestrini","year":"2020","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jocn.2021.10.041_b0130","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-017-0801-1","article-title":"Complex regulation of neutrophil-derived MMP-9 secretion in central nervous system tuberculosis","volume":"14","author":"Ong","year":"2017","journal-title":"J Neuroinflamm"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586821005476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586821005476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:30:55Z","timestamp":1760823055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586821005476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":26,"alternative-id":["S0967586821005476"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2021.10.041","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes of FSTL1 and MMP-9 levels in patients with acute cerebral infarction and its relationship with hemorrhagic transformation","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2021.10.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}